# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-20-005469
Filing Date
2020-03-17
Accepted
2020-03-17 16:06:25
Documents
69
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dffn20191231_10k.htm | 10-K | 1248767
2 | EXHIBIT 4.12 | ex_176595.htm | EX-4.12 | 17779
3 | EXHIBIT 21.1 | ex_176566.htm | EX-21.1 | 4812
4 | EXHIBIT 23.1 | ex_177424.htm | EX-23.1 | 3532
5 | EXHIBIT 31.1 | ex_176499.htm | EX-31.1 | 15932
6 | EXHIBIT 31.2 | ex_176500.htm | EX-31.2 | 15870
7 | EXHIBIT 32.1 | ex_176501.htm | EX-32.1 | 5980
14 |  | dffn20191231_10kimg003.gif | GRAPHIC | 19139
15 |  | dffn20191231_10kimg004.gif | GRAPHIC | 86871
16 |  | dffn20191231_10kimg005.jpg | GRAPHIC | 9717
17 |  | dffn20191231_10kimg006.jpg | GRAPHIC | 28630
18 |  | img01.jpg | GRAPHIC | 22681
19 |  | picture1.jpg | GRAPHIC | 61938
| Complete submission text file | 0001437749-20-005469.txt |  | 4961585

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE DOCUMENT | dffn-20191231.xml | EX-101.INS | 781035
9 | XBRL TAXONOMY EXTENSION SCHEMA | dffn-20191231.xsd | EX-101.SCH | 48356
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dffn-20191231_cal.xml | EX-101.CAL | 33555
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dffn-20191231_def.xml | EX-101.DEF | 299546
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dffn-20191231_lab.xml | EX-101.LAB | 291062
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dffn-20191231_pre.xml | EX-101.PRE | 329215

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 20720977
SIC: 2834 Pharmaceutical Preparations